BELLEVUE
0841.241.408 · rovalta.com · 22/09/2026
BELLEVUE
Overview
What does BELLEVUE do?
BELLEVUE is a Public limited company incorporated in 2011. Its main activity is: Activities of holding companies. Its registered office is in Gent.
9052 Gent · FlandreSee on map
Joint committees (1)
- 200
Trend over 10 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2016 | 2015 | 2014 | 2013 | 2012 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||
| Gross margin | 515,8 k € | -9.3% | 568,5 k € | +194% | 193,1 k € | +150% | -385,9 k € | -415% | -74,9 k € | -133% | 227,8 k € | +4.0% | 219,1 k € | +2425% | -9,4 k € | -370% | -2 k € | +45.7% | -3,7 k € |
| EBITDA | 475,1 k € | -15.4% | 561,7 k € | +233% | 168,6 k € | +118% | -937,7 k € | -930% | -91 k € | -152% | 176,2 k € | +7.1% | 164,5 k € | +1827% | -9,5 k € | -289% | -2,4 k € | +44.4% | -4,4 k € |
| Operating result | 204,3 k € | -50.3% | 411,3 k € | +1678% | 23,1 k € | +102% | -1 M € | -632% | -139,1 k € | -181% | 172,6 k € | +7.3% | 160,9 k € | +1331% | -13,1 k € | -118% | -6 k € | +7.4% | -6,5 k € |
| Net result | -186,6 k € | -147% | 394,3 k € | -98.8% | 34,1 M € | +2363% | -1,5 M € | -336% | -344,9 k € | -117% | 2,1 M € | +14033% | 14,8 k € | +213% | 4,7 k € | -51.3% | 9,7 k € | +250% | -6,5 k € |
| Balance sheet | |||||||||||||||||||
| Equity | 45,6 M € | -0.4% | 45,7 M € | +0.9% | 45,3 M € | +334% | 10,4 M € | -12.6% | 11,9 M € | +6.2% | 11,2 M € | -57.0% | 26,2 M € | +43.6% | 18,2 M € | +9.7% | 16,6 M € | +0.1% | 16,6 M € |
| Total assets | 54,5 M € | +5.1% | 51,9 M € | +2.3% | 50,7 M € | +7.5% | 47,2 M € | +93.1% | 24,4 M € | +11.6% | 21,9 M € | -29.1% | 30,9 M € | +58.7% | 19,5 M € | +9.0% | 17,8 M € | +2.2% | 17,5 M € |
| Cash | 120,2 k € | +239% | 35,4 k € | -47.6% | 67,6 k € | +142% | 28 k € | 0 € | -100% | 10,7 k € | -97.4% | 419,3 k € | – | 194,8 € | -99.9% | 279,8 k € | |||
| Debts | 9 M € | +45.9% | 6,2 M € | +14.3% | 5,4 M € | -85.3% | 36,8 M € | +195% | 12,5 M € | +20.7% | 10,3 M € | +128% | 4,5 M € | +271% | 1,2 M € | -0.3% | 1,2 M € | +42.5% | 862,5 k € |
| Other | |||||||||||||||||||
| Workforce | 0,0 ETP | 0,0 ETP | 0,0 ETP | – | – | 1,0 ETP | 0.0% | 1,0 ETP | – | – | – | ||||||||
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 30/06/2025 · 1 active · 17 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
BORDEAUX I● Active | 0839.861.632 |
CARDON BIO● Active | 0782.633.810 |
CELL-CELL BIO● Active | 0782.638.362 |
DOING WELL BY DOING GOOD● Active | 0476.250.994 |
RNA Pioneering● Active | 0456.792.695 |
Ziphius● Active | 0750.500.975 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/07/2020 | 01/07/2019 |
| Closing of the financial year | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 29/01/2026 | 06/02/2025 | 31/01/2024 | 27/01/2023 | 28/07/2022 | 27/01/2021 |
| General meeting | 27/01/2026 | 30/01/2025 | 31/01/2024 | 25/01/2023 | 27/07/2022 | 28/11/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
14 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 30/06/2025 | 27/01/2026 | 29/01/2026 | Dutch | |
| Abridged model | 30/06/2024 | 30/01/2025 | 06/02/2025 | Dutch | |
| Abridged model | 30/06/2023 | 31/01/2024 | 31/01/2024 | Dutch | |
| Abridged model | 30/06/2022 | 25/01/2023 | 27/01/2023 | Dutch | |
| Abridged model | 30/06/2021 | 27/07/2022 | 28/07/2022 | Dutch | |
| Abridged model | 30/06/2020 | 28/11/2020 | 27/01/2021 | Dutch | |
| Abridged model | 30/06/2019 | 30/12/2019 | 29/01/2020 | Dutch | |
| Abridged model | 30/06/2018 | 24/11/2018 | 08/01/2019 | Dutch | |
| Abridged model | 30/06/2017 | 29/12/2017 | 12/03/2018 | Dutch | |
| Abridged model | 30/06/2016 | 31/12/2016 | 07/03/2017 | Dutch | |
| Abridged model | 30/06/2015 | 31/12/2015 | 10/08/2016 | Dutch | |
| Abridged model | 30/06/2014 | 31/12/2014 | 15/01/2015 | Dutch | |
| Abridged model | 30/06/2013 | 31/12/2013 | 14/02/2014 | Dutch | |
| Abridged model | 30/06/2012 | 31/12/2012 | 14/02/2013 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 30/06/2025 · 1 active · 17 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Registered office22/08/2024MAATSCHAPPELIJKE ZETEL
- Registered office10/11/2022MAATSCHAPPELIJKE ZETEL
- Restructuring29/07/2022RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...) - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Restructuring02/12/2021RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Restructuring02/12/2021RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Registered office14/02/2020MAATSCHAPPELIJKE ZETEL
- Restructuring15/10/2018KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Restructuring16/08/2018RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-186,6 k €↓
- 2024Annual accounts 2024394,3 k €↓
- 2023Annual accounts 202334,1 M €↑
- 2022Annual accounts 2022-1,5 M €↓
- 2021Annual accounts 2021-344,9 k €↓
- 2016Annual accounts 20162,1 M €↑
- 2015Annual accounts 201514,8 k €↑
- 2014Annual accounts 20144,7 k €↓
- 2013Annual accounts 20139,7 k €↑
- 2012Annual accounts 2012-6,5 k €
- 22/11/2011IncorporationPublic limited company